Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial (Q29619975)
scientific article (publication date: February 2010)
Language:
(P31) (Q13442814)
(P304) 121-8
(P407) (Q1860)
(P433) 2
(P478) 11
(P577) +2010-02-00T00:00:00Z
(P921) (Q42824827)
(Q181600)
(Q47912)
(Q420436)
(Q412415)
(P1433) (Q13747613)
(P1476) "Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial" (language: en)
(P2093) Mitsudomi T
Morita S
Yatabe Y
Negoro S
Okamoto I
Tsurutani J
Seto T
Satouchi M
Tada H
Hirashima T
Asami K
Katakami N
Takada M
Yoshioka H
Shibata K
Kudoh S
Shimizu E
Saito H
Toyooka S
Nakagawa K
Fukuoka M
(P2860) (Q29547625)
(Q29615476)
(Q37394447)
(Q29615473)
(Q34533636)
(Q34271566)
(Q27861059)
(Q27824812)
(Q45190258)
(Q36494159)
(Q45966957)
(Q24625201)
(Q29619696)
(Q34555510)
(Q46585170)
(Q34596877)
(Q29620605)
(Q46232500)
(Q35790221)
(Q40384287)
(Q29396936)
(Q46618741)
(Q27860881)
(Q43279489)
(Q46704761)
(Q51802507)
other details
description scientific article (publication date: February 2010)

External Links